Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,592
Total Claims
$3.9M
Drug Cost
539
Beneficiaries
$7,204
Cost/Patient
Risk Score Breakdown 7/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-37%
Opioid rate vs peers
1.4% vs 2.2% avg
+411%
Cost per patient vs peers
$7,204 vs $1,411 avg
+66%
Brand preference vs peers
17.7% vs 10.6% avg
Opioid Prescribing
1.4%
Opioid Rate
150
Opioid Claims
$1,832
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,853 claims · $3.6M
Generic: 8,643 claims · $266K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Bictegrav/Emtricit/Tenofov Ala | 175 | $715K |
| Elviteg/Cob/Emtri/Tenof Alafen | 124 | $489K |
| Abacavir/Dolutegravir/Lamivudi | 84 | $307K |
| Darunavir/Cob/Emtri/Tenof Alaf | 39 | $189K |
| Dolutegravir/Rilpivirine | 43 | $154K |
| Emtricitabine/Tenofov Alafenam | 66 | $153K |
| Dulaglutide | 64 | $143K |
| Darunavir/Cobicistat | 50 | $129K |
| Dolutegravir Sodium/Lamivudine | 32 | $96K |
| Dolutegravir Sodium | 38 | $93K |
| Raltegravir Potassium | 45 | $92K |
| Budesonide/Formoterol Fumarate | 80 | $80K |
| Apixaban | 51 | $77K |
| Darunavir | 27 | $60K |
| Emtricitab/Rilpiviri/Tenof Ala | 15 | $55K |
Prescribing Profile
Patient Profile
66
Avg Age
48%
Female
1.78
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data